{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:50:56Z","timestamp":1740163856112,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K09341","JP19K09342","JP18K08807","JP17H04319"],"award-info":[{"award-number":["JP19K09341","JP19K09342","JP18K08807","JP17H04319"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Older adult patients with sepsis frequently experience cognitive impairment. The roles of brain neutrophil gelatinase-associated lipocalin (NGAL) and iron in older sepsis patients remain unknown. We investigated the effects of lipopolysaccharide-induced sepsis on novel object recognition test, NGAL levels, an inflammatory mediator tumor necrosis factor-\u03b1 (TNF\u03b1) levels, and iron ion levels in the hippocampus and cortex of young and aged rats. The effect of an iron chelator deferoxamine pretreatment on aged sepsis rats was also examined. Young sepsis-survivor rats did not show impaired novel object recognition, TNF\u03b1 responses, or a Fe<jats:sup>2+<\/jats:sup>\/Fe<jats:sup>3+<\/jats:sup> imbalance. They showed hippocampal and cortical NGAL level elevations. Aged sepsis-survivor rats displayed a decreased object discrimination index, elevation of NGAL levels and Fe<jats:sup>2+<\/jats:sup>\/Fe<jats:sup>3+<\/jats:sup> ratio, and no TNF\u03b1 responses. Pretreatment with deferoxamine prevented the reduction in the object recognition of aged sepsis-survivor rats. The elevation in hippocampal and cortical NGAL levels caused by lipopolysaccharide was not influenced by deferoxamine pretreatment. The lipopolysaccharide-induced Fe<jats:sup>2+<\/jats:sup>\/Fe<jats:sup>3+<\/jats:sup> ratio elevation was blocked by deferoxamine pretreatment. In conclusion, our findings suggest that iron homeostasis in the cortex and hippocampus contributes to the maintenance of object recognition ability in older sepsis survivors.<\/jats:p>","DOI":"10.1038\/s41598-021-03981-7","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T11:03:21Z","timestamp":1641553401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of neutrophil gelatinase-associated lipocalin and iron homeostasis in object recognition impairment in aged sepsis-survivor rats"],"prefix":"10.1038","volume":"12","author":[{"given":"Yoshikazu","family":"Nikaido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Midorikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Takekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Kushikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"key":"3981_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"3981_CR2","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","volume":"304","author":"TJ Iwashyna","year":"2010","unstructured":"Iwashyna, T. J., Ely, E. W., Smith, D. M. & Langa, K. M. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304, 1787\u20131794 (2010).","journal-title":"JAMA"},{"key":"3981_CR3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jnnp-2012-302883","volume":"84","author":"A Semmler","year":"2013","unstructured":"Semmler, A. et al. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J. Neurol. Neurosurg. Psychiatry 84, 62\u201369 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"3981_CR4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fimmu.2017.00597","volume":"8","author":"SJ Kuperberg","year":"2017","unstructured":"Kuperberg, S. J. & Wadgaonkar, R. Sepsis-associated encephalopathy: The blood\u2013brain barrier and the sphingolipid rheostat. Front. Immunol. 8, 597 (2017).","journal-title":"Front. Immunol."},{"key":"3981_CR5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1096\/fj.05-3776fje","volume":"19","author":"JP Godbout","year":"2005","unstructured":"Godbout, J. P. et al. Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system. FASEB J. 19, 1329\u20131331 (2005).","journal-title":"FASEB J."},{"key":"3981_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbi.2008.09.002","volume":"23","author":"CJ Henry","year":"2009","unstructured":"Henry, C. J., Huang, Y., Wynne, A. M. & Godbout, J. P. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1\u03b2 and anti-inflammatory IL-10 cytokines. Brain Behav. Immun. 23, 309\u2013317 (2009).","journal-title":"Brain Behav. Immun."},{"key":"3981_CR7","volume":"99","author":"X Hou","year":"2020","unstructured":"Hou, X. et al. The value of neutrophil gelatinase-associated lipocalin and citrullinated alpha enolase peptide-1 antibody in diagnosis, classification, and prognosis for patients with sepsis. Medicine 99, e21893 (2020).","journal-title":"Medicine"},{"key":"3981_CR8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pneurobio.2015.06.005","volume":"131","author":"AC Ferreira","year":"2015","unstructured":"Ferreira, A. C. et al. From the periphery to the brain: Lipocalin-2, a friend or foe?. Prog. Neurobiol. 131, 120\u2013136 (2015).","journal-title":"Prog. Neurobiol."},{"key":"3981_CR9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03104","volume":"432","author":"TH Flo","year":"2004","unstructured":"Flo, T. H. et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917\u2013921 (2004).","journal-title":"Nature"},{"key":"3981_CR10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1742-2094-8-124","volume":"8","author":"JPK Ip","year":"2011","unstructured":"Ip, J. P. K. et al. Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. J. Neuroinflamm. 8, 124 (2011).","journal-title":"J. Neuroinflamm."},{"key":"3981_CR11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12974-018-1372-5","volume":"5","author":"DW Dekens","year":"2018","unstructured":"Dekens, D. W. et al. Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model. J. Neuroinflamm. 5, 330 (2018).","journal-title":"J. Neuroinflamm."},{"key":"3981_CR12","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.179.5.3231","volume":"179","author":"S Lee","year":"2007","unstructured":"Lee, S. et al. A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J. Immunol. 179, 3231\u20133241 (2007).","journal-title":"J. Immunol."},{"key":"3981_CR13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1523\/JNEUROSCI.5273-08.2009","volume":"29","author":"S Lee","year":"2009","unstructured":"Lee, S. et al. Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J. Neurosci. 29, 234\u2013249 (2009).","journal-title":"J. Neurosci."},{"key":"3981_CR14","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/cdd.2014.68","volume":"21","author":"SD Mesquita","year":"2014","unstructured":"Mesquita, S. D. et al. Lipocalin 2 modulates the cellular response to amyloid beta. Cell Death Differ. 21, 1588\u20131599 (2014).","journal-title":"Cell Death Differ."},{"key":"3981_CR15","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/glia.22342","volume":"60","author":"JL Berard","year":"2012","unstructured":"Berard, J. L. et al. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia 60, 1145\u20131159 (2012).","journal-title":"Glia"},{"key":"3981_CR16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/mp.2016.243","volume":"23","author":"SS Kang","year":"2018","unstructured":"Kang, S. S. et al. Lipocalin-2 protects the brain during inflammatory conditions. Mol. Psychiatry 23, 344\u2013350 (2018).","journal-title":"Mol. Psychiatry"},{"key":"3981_CR17","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/STROKEAHA.114.005733","volume":"45","author":"C Xing","year":"2014","unstructured":"Xing, C. et al. Neuronal production of lipocalin-2 as a help-me signal for glial activation. Stroke 45, 2085\u20132092 (2014).","journal-title":"Stroke"},{"key":"3981_CR18","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.283","volume":"5","author":"T Furukawa","year":"2017","unstructured":"Furukawa, T. et al. Chronic diazepam administration increases the expression of Lcn2 in the CNS. Pharmacol. Res. Perspect. 5, e00283 (2017).","journal-title":"Pharmacol. Res. Perspect."},{"key":"3981_CR19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40560-020-00495-8","volume":"8","author":"A Brandtner","year":"2020","unstructured":"Brandtner, A. et al. Linkage of alterations in systemic iron homeostasis to patients\u2019 outcome in sepsis: A prospective study. J. Intensive Care 8, 76 (2020).","journal-title":"J. Intensive Care"},{"key":"3981_CR20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R. & Zecca, L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 13, 1045\u20131060 (2014).","journal-title":"Lancet Neurol."},{"key":"3981_CR21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/cc13110","volume":"17","author":"E L\u00f3pez-Collazo","year":"2013","unstructured":"L\u00f3pez-Collazo, E. & del Fresno, C. Pathophysiology of endotoxin tolerance: Mechanisms and clinical consequences. Crit. Care. 17, 242 (2013).","journal-title":"Crit. Care."},{"key":"3981_CR22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbi.2021.07.002","volume":"97","author":"B Olson","year":"2021","unstructured":"Olson, B. et al. Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment. Brain Behav. Immune. 97, 102\u2013118 (2021).","journal-title":"Brain Behav. Immune."},{"key":"3981_CR23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/jcbfm.2012.21","volume":"32","author":"KB Hota","year":"2012","unstructured":"Hota, K. B., Hota, S. K., Srivastava, R. B. & Singh, S. B. Neuroglobin regulates hypoxic response of neuronal cells through Hif-1\u03b1- and Nrf2-mediated mechanism. J. Cereb. Blood Flow Metab. 32, 1046\u20131060 (2012).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"3981_CR24","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/brain\/awx137","volume":"140","author":"S Ayton","year":"2017","unstructured":"Ayton, S. et al. Cerebral quantitative susceptibility mapping predicts amyloid-\u03b2-related cognitive decline. Brain 140, 2112\u20132119 (2017).","journal-title":"Brain"},{"key":"3981_CR25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/jnnp-2019-322042","volume":"91","author":"GEC Thomas","year":"2020","unstructured":"Thomas, G. E. C. et al. Brain iron deposition is linked with cognitive severity in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry. 91, 418\u2013425 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"3981_CR26","doi-asserted-by":"crossref","first-page":"101789","DOI":"10.1016\/j.redox.2020.101789","volume":"38","author":"C Fern\u00e1ndez-Mend\u00edvil","year":"2021","unstructured":"Fern\u00e1ndez-Mend\u00edvil, C. et al. Protective role of microglial HO-1 blockade in aging: Implication of iron metabolism. Redox Biol. 38, 101789 (2021).","journal-title":"Redox Biol."},{"key":"3981_CR27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/antiox9070644","volume":"9","author":"C Fern\u00e1ndez-Mend\u00edvil","year":"2020","unstructured":"Fern\u00e1ndez-Mend\u00edvil, C., Arreola, M. A., Hohsfield, L. A., Green, K. N. & L\u00f3pez, M. G. Aging and progression of beta-amyloid pathology in alzheimer\u2019s disease correlates with microglial heme-oxygenase-1 overexpression. Antioxidants 9, 644 (2020).","journal-title":"Antioxidants"},{"key":"3981_CR28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2011-102061","volume":"26","author":"Y Hui","year":"2011","unstructured":"Hui, Y. et al. Long-term overexpression of heme oxygenase 1 promotes tau aggregation in mouse brain by inducing tau phosphorylation. J. Alzheimers Dis. 26, 299\u2013313 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"3981_CR29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/jnc.12244","volume":"126","author":"P Urrutia","year":"2013","unstructured":"Urrutia, P. et al. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J. Neurochem. 126, 541\u2013549 (2013).","journal-title":"J. Neurochem."},{"key":"3981_CR30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","volume":"12","author":"WA Banks","year":"2015","unstructured":"Banks, W. A. et al. Lipopolysaccharide-induced blood-brain barrier disruption: Roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J. Neuroinflamm. 12, 223 (2015).","journal-title":"J. Neuroinflamm."},{"key":"3981_CR31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-4274(01)00541-0","volume":"128","author":"V Eybl","year":"2002","unstructured":"Eybl, V., Kotyzov\u00e1, D., Kolek, M., Koutensk\u00fd, J. & Nielsen, P. The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice. Toxicol. Lett. 128, 169\u2013175 (2002).","journal-title":"Toxicol. Lett."},{"key":"3981_CR32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12974-015-0238-3","volume":"12","author":"XY Zhang","year":"2015","unstructured":"Zhang, X. Y., Cao, J. B., Zhang, L. M., Li, Y. F. & Mi, W. D. Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice. J. Neuroinflamm. 12, 20 (2015).","journal-title":"J. Neuroinflamm."},{"key":"3981_CR33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jnc.13425","volume":"139","author":"AA Belaidi","year":"2016","unstructured":"Belaidi, A. A. & Bush, A. I. Iron neurochemistry in Alzheimer\u2019s disease and Parkinson\u2019s disease: Targets for therapeutics. J. Neurochem. 139, 179\u2013197 (2016).","journal-title":"J. Neurochem."},{"key":"3981_CR34","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41591-019-0673-2","volume":"25","author":"B Lehallier","year":"2019","unstructured":"Lehallier, B. et al. Undulating changes in human plasma proteome profiles across the lifespan. Nat. Med. 25, 1843\u20131850 (2019).","journal-title":"Nat. Med."},{"key":"3981_CR35","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1086\/523108","volume":"196","author":"CM Kim","year":"2007","unstructured":"Kim, C. M., Park, Y. J. & Shin, S. H. A widespread deferoxamine-mediated iron-uptake system in Vibrio vulnificus. J. Infect. Dis. 196, 1537\u20131545 (2007).","journal-title":"J. Infect. Dis."},{"key":"3981_CR36","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.micinf.2014.09.003","volume":"16","author":"AJ Arifin","year":"2014","unstructured":"Arifin, A. J., Hannauer, M., Welch, I. & Heinrichs, D. E. Deferoxamine mesylate enhances virulence of community-associated methicillin resistant Staphylococcus aureus. Microbes Infect. 16, 967\u2013972 (2014).","journal-title":"Microbes Infect."},{"key":"3981_CR37","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1161\/STROKEAHA.111.617589","volume":"42","author":"M Selim","year":"2011","unstructured":"Selim, M. et al. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke 42, 3067\u20133074 (2011).","journal-title":"Stroke"},{"key":"3981_CR38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1474-4422(19)30069-9","volume":"18","author":"M Selim","year":"2019","unstructured":"Selim, M. et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): A multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 18, 428\u2013438 (2019).","journal-title":"Lancet Neurol."},{"key":"3981_CR39","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/STROKEAHA.108.535765","volume":"40","author":"M Okauchi","year":"2009","unstructured":"Okauchi, M., Hua, Y., Keep, R. F., Morgenstern, L. B. & Xi, G. Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke 40, 1858\u20131863 (2009).","journal-title":"Stroke"},{"key":"3981_CR40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ALN.0000000000000697","volume":"123","author":"T Kawano","year":"2015","unstructured":"Kawano, T. et al. Impact of preoperative environmental enrichment on prevention of development of cognitive impairment following abdominal surgery in a rat model. Anesthesiology 123, 160\u2013170 (2015).","journal-title":"Anesthesiology"},{"key":"3981_CR41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbr.2015.10.023","volume":"297","author":"Y Nikaido","year":"2016","unstructured":"Nikaido, Y. et al. Cis-3-Hexenol and trans-2-hexenal mixture prevents development of PTSD-like phenotype in rats. Behav. Brain Res. 297, 251\u2013258 (2016).","journal-title":"Behav. Brain Res."},{"key":"3981_CR42","volume":"9","author":"SM Leal Jr","year":"2013","unstructured":"Leal, S. M. Jr. et al. Targeting iron acquisition blocks infection with the fungal pathogens Aspergillus fumigatus and Fusarium oxysporum. PLOS Pathog. 9, e1003436 (2013).","journal-title":"PLOS Pathog."},{"key":"3981_CR43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul, F., Erdfelder, E., Lang, A. G. & Buchner, A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39, 175\u2013191 (2007).","journal-title":"Behav. Res. Methods"},{"key":"3981_CR44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.22237\/jmasm\/1509496200","volume":"16","author":"M \u00d6\u0308ner","year":"2017","unstructured":"\u00d6\u0308ner, M. & Kocako\u00e7, I\u0307. D. JMASM 49: A compilation of some popular goodness of fit tests for normal distribution: Their algorithms and MATLAB codes (MATLAB). J. Mod. Appl. Stat. Methods. 16, 547\u2013575 (2017).","journal-title":"J. Mod. Appl. Stat. Methods."},{"key":"3981_CR45","unstructured":"Borau, C. BoxPlotPro. MATLAB Central File Exchange. Retrieved May 14, 2021 from https:\/\/www.mathworks.com\/matlabcentral\/fileexchange\/88733-boxplotpro (2021)."},{"key":"3981_CR46","unstructured":"Cardillo, G. LogRank: Comparing survival curves of two groups using the log rank test. MATLAB Central File Exchange. Retrieved May 14, 2021 from http:\/\/www.mathworks.com\/matlabcentral\/fileexchange\/22317 (2021)."},{"key":"3981_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v064.i09","volume":"64","author":"F Konietschke","year":"2015","unstructured":"Konietschke, F., Placzek, M., Schaarschmidt, F. & Hothorn, L. nparcomp: An R software package for nonparametric multiple comparisons and simultaneous confidence intervals. J. Stat. Softw. 64, 1\u201317 (2015).","journal-title":"J. Stat. Softw."},{"key":"3981_CR48","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.21105\/joss.02815","volume":"5","author":"M Ben-Shachar","year":"2020","unstructured":"Ben-Shachar, M., L\u00fcdecke, D. & Makowski, D. effectsize: Estimation of effect size indices and standardized parameters. J. Open Source Softw. 5, 2815 (2020).","journal-title":"J. Open Source Softw."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03981-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03981-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03981-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:11:26Z","timestamp":1669320686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03981-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3981"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-03981-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"8 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.N. belongs to the Department of Frailty Research and Prevention, Hirosaki University Graduate School of Medicine, in collaboration with FANCL Corporation, Tokyo, Japan. The company had no role in the study\u2019s design; the collection, analysis, interpretation of the data; the writing of the manuscript; or the decision to submit the manuscript for publication. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}